Research and Clinical Trials

Meet the investigator: Tanios S. Bekaii-Saab

By Nicole Ferrara • December 14, 2018
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Tanios S. Bekaii-Saab, M.D., a medical oncologist at Mayo Clinic in Phoenix/Scottsdale, Arizona, explains how his research interests grew out of a desire to improve treatment options for his patients.

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.

Smoldering multiple myeloma: What it is, how it progresses and the latest research

Drs. Vincent Rajkumar and Rafael Fonseca explain what smoldering multiple myeloma is and how treating it could potentially delay or prevent multiple myeloma.

Mayo Clinic discovers new role for protein to fight tumors

Researchers have discovered a new role that a protein known as NKG7 plays in regulating cell resistance and fighting tumors in certain types of cancer.